title: [Acute myelogenous leukemia associated with severe esophageal stricture after chemotherapy].
abstract: A 41-year-old woman with relapsed acute myelogenous leukemia was treated twice with idarubicin hydrochloride and cytarabine. She developed a 6-cm-long stricture in the lower esophagus 12 days after re-induction therapy. Although she had preceding candida infection, it is suspected that her stricture was caused by mucosal damage due to chemotherapeutic agents. This case suggests that the possibility of esophageal stricture should be considered in patients with swallowing disturbance after intensive chemotherapy.
authors.affiliation: Division of Hematology, Department of Medicine, Kawasaki Medical School.
authors.forename: Kenichiro
authors.initials: K
authors.lastname: Yata
authors.forename: Osamu
authors.initials: O
authors.lastname: Yamada
authors.forename: Koji
authors.initials: K
authors.lastname: Iwato
authors.forename: Taiichi
authors.initials: T
authors.lastname: Kyo
authors.forename: Takemi
authors.initials: T
authors.lastname: Otsuki
authors.forename: Hidekazu
authors.initials: H
authors.lastname: Nakanishi
authors.forename: Yoshimasa
authors.initials: Y
authors.lastname: Suetsugu
authors.forename: Makoto
authors.initials: M
authors.lastname: Mikami
authors.forename: Hideho
authors.initials: H
authors.lastname: Wada
authors.forename: Yoshihito
authors.initials: Y
authors.lastname: Yawata
authors.forename: Takashi
authors.initials: T
authors.lastname: Sugihara
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004940:Esophageal Stenosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000009:adverse effects; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*
chemical_list: D003561:Cytarabine; D015255:Idarubicin